Navigation Links
National Patient Advocate Foundation Supports 340B Drug Discount Program Review Identifying Risks to Underinsured Patients
Date:2/13/2013

WASHINGTON, Feb. 13, 2013 /PRNewswire-USNewswire/ -- "As part of our mission to serve as the patient voice in improving access to, and reimbursement for, high-quality healthcare for millions of Americans, NPAF is proud to be part of important research related to the 340B Drug Discount Program, particularly in light of federal budgetary cuts in health care provider services.  Originally created by Congress in 1992 to help uninsured indigent patients gain better access to prescription medicines, the program requires pharmaceutical manufacturers to provide discounts on outpatient prescription drugs to entities that serve high numbers of uninsured indigent patients.

"More than 20 years after its creation, the 340B program appears to have strayed from its original purpose, leading to this recent analysis by our broad-based group of providers, pharmacists, patients and innovators. Among the potentially serious consequences highlighted in today's White Paper are concerns that some uninsured indigent patients may not be experiencing direct benefit from the program's existence; anecdotal evidence that clinical decision-making may be skewed by efforts to take advantage of the 340B discount; and growing evidence of displacement of non-340B providers who serve a key role in providing patient access to important health care services. Therefore, improved transparency and oversight of the 340B program is needed to ensure it remains aligned with its original intent.

"NPAF feels very strongly that this is a critical program today and going forward for the many patients who are uninsured and of indigent status. Because of the importance of the program, and due to our recent findings, we fully support and encourage a thorough examination of the 340B program by Congress to ensure it is meeting its original goals for the millions of Americans who depend upon it."

National Patient Advocate Foundation is a national non-profit organization providing the patient voice in improving access to, and reimbursement for, high-quality healthcare through regulatory and legislative reform at the state and federal levels. NPAF translates the experience of millions of patients who have been helped by our companion, Patient Advocate Foundation, which provides professional case management services to individuals facing barriers to healthcare access for chronic and disabling disease, medical debt crisis and employment-related issues at no cost. If you are in need of direct patient services, please contact Patient Advocate Foundation at 1-800-532-5274 or on the web at www.patientadvocate.org.


'/>"/>
SOURCE National Patient Advocate Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Companys Growth and International Expansion Plan
2. MGC Diagnostics Corporation Announces National Jewish Health Selects the Company as Preferred Provider for Cardiopulmonary Diagnostic Instrumentation
3. Prime Therapeutics named a 2013 National Top Workplace
4. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
5. Rafarma Pharmaceuticals, Inc. Named 1 Of 4 National Strategic Pharmaceutical Suppliers To The Russian Federation
6. Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
7. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
8. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
9. NSF International Acquires the INASSA Group LLC, a Peruvian Leader in Analytical Testing, Certification, Inspection and Training for the Seafood/Fishing, Food and Pharmaceutical/Medical Industries
10. Life Technologies Establishes International Influenza Network
11. Tang Prize Foundation Established in Taiwan: Academia Sinica to be Responsible for the Nomination and Selection of the International Awards in Taiwan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):